logo

Plus Therapeutics Inc. (PSTV)



Trade PSTV now with
  Date
  Headline
11/19/2020 8:20:34 AM Plus Therapeutics Announces Positive New Interim Data From ReSPECT Phase 1 Clinical Trial
9/15/2020 7:24:48 AM Plus Therapeutics Receives Fast Track Designation For Rhenium NanoLiposomes From FDA For Recurrent Glioblastoma
9/1/2020 7:19:54 AM Plus Therapeutics Says FDA Granted Orphan Drug Designation For Rhenium NanoLiposomes
4/1/2020 7:16:06 AM Plus Therapeutics Names Gregory Stein SVP Of Clinical Development
3/12/2020 7:22:55 AM Plus Therapeutics Names Robert Lenk And Howard Clowes Independent Directors, Effective April 1
2/6/2020 5:02:07 PM Plus Therapeutics Appoints Andrew Sims As CFO
1/2/2020 4:36:41 PM Plus Therapeutics Appoints An Van Es-Johansson To Board Of Directors